nabil saba
nabil saba
Unknown affiliation
Verified email at
Cited by
Cited by
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
N Engl J Med 375, 1856-1867, 2016
Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytes
AS Shet, O Aras, K Gupta, MJ Hass, DJ Rausch, N Saba, L Koopmeiners, ...
Blood 102 (7), 2678-2683, 2003
Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study
J Bauml, TY Seiwert, DG Pfister, F Worden, SV Liu, J Gilbert, NF Saba, ...
Journal of Clinical Oncology 35 (14), 1542, 2017
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by …
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
Oral oncology 81, 45-51, 2018
An update on larynx cancer
CE Steuer, M El‐Deiry, JR Parks, KA Higgins, NF Saba
CA: a cancer journal for clinicians 67 (1), 31-50, 2017
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related …
KJ Harrington, RL Ferris, G Blumenschein Jr, AD Colevas, J Fayette, ...
The Lancet Oncology 18 (8), 1104-1115, 2017
Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973‐2007 surveillance, epidemiology, and end results data
CL Ellington, M Goodman, SA Kono, W Grist, T Wadsworth, AY Chen, ...
Cancer 118 (18), 4444-4451, 2012
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009
B Ansa, M Goodman, K Ward, SA Kono, TK Owonikoko, K Higgins, ...
Cancer 119 (14), 2602-2610, 2013
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial
LL Siu, C Even, R Mesía, E Remenar, A Daste, JP Delord, J Krauss, ...
JAMA oncology 5 (2), 195-203, 2019
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
P Strojan, JB Vermorken, JJ Beitler, NF Saba, M Haigentz Jr, P Bossi, ...
Head & neck 38 (S1), E2151-E2158, 2016
Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results …
NF Saba, M Goodman, K Ward, C Flowers, S Ramalingam, T Owonikoko, ...
Oncology 81 (1), 12-20, 2011
High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant
N Saba, DM Sutton, HJ Ross, S Siu, RM Crump, A Keating, AK Stewart
Bone marrow transplantation 24 (8), 853-855, 1999
ACR Appropriateness Criteria® Retreatment of Recurrent Head and Neck Cancer After Prior Definitive Radiation: Expert Panel on Radiation Oncology–Head and Neck Cancer
MW McDonald, J Lawson, MK Garg, H Quon, JA Ridge, N Saba, ...
International Journal of Radiation Oncology* Biology* Physics 80 (5), 1292-1298, 2011
Nasal juvenile angiofibroma: Current perspectives with emphasis on management
F López, A Triantafyllou, CH Snyderman, JL Hunt, C Suárez, VJ Lund, ...
Head & neck 39 (5), 1033-1045, 2017
The role of systemic therapy in the management of sinonasal cancer: a critical review
P Bossi, NF Saba, JB Vermorken, P Strojan, L Pala, R De Bree, ...
Cancer treatment reviews 41 (10), 836-843, 2015
Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection
RS Prabhu, KR Magliocca, S Hanasoge, AH Aiken, PA Hudgins, WA Hall, ...
International Journal of Radiation Oncology* Biology* Physics 88 (1), 122-129, 2014
Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma
JS Carr, SF Zafar, N Saba, FR Khuri, BF El-Rayes
Journal of gastrointestinal cancer 44 (2), 143-151, 2013
Distinctive E‐cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation
S Muller, L Su, M Tighiouart, N Saba, H Zhang, DM Shin, Z Chen
Cancer 113 (1), 97-107, 2008
Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: efficacy and safety in CheckMate 141 by prior cetuximab use
RL Ferris, L Licitra, J Fayette, C Even, G Blumenschein, KJ Harrington, ...
Clinical Cancer Research 25 (17), 5221-5230, 2019
Management of locally recurrent nasopharyngeal carcinoma
AWM Lee, WT Ng, JYW Chan, J Corry, A Mäkitie, WM Mendenhall, ...
Cancer treatment reviews 79, 101890, 2019
The system can't perform the operation now. Try again later.
Articles 1–20